Enhance Radiation Accuracy with Cherenkov Imaging
Dose Visualization to Help Prevent Treatment Errors
Even minor radiation delivery errors can compromise outcomes or harm healthy tissue. Studies show that 2.6%¹ of breast cancer patients develop secondary contralateral cancers linked to radiation, and up to 10%² of patients experience detectable treatment errors.
BeamSite, powered by Cherenkov imaging, enables real-time, in-vivo visualization of radiation dose as it’s delivered.
Benefits of Cherenkov Imaging:
Real-Time Dose Monitoring
Real-time dose visualization to help enhance accuracy during treatment delivery.
Enhanced Treatment Visibility
Helps identify potential delivery errors to support safer, more informed clinical decision-making.
Retrospective Quality Assurance
Supports post-treatment review to identify and analyze discrepancies in delivered dose.
Solutions:
BeamSite®
BeamSite is the standalone Cherenkov imaging solution. It provides all the benefits of Cherenkov imaging without the motion monitoring integration.
- Jarvis et al.(2021) Initial Clinical Experience of Cherenkov Imaging in External Beam Radiation Therapy Identifies Opportunities to Improve Treatment Delivery. Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1627-1637.
- Burt LM, Ying J, Poppe MM, Suneja G, Gaffney DK.(2017) Risk of secondary malignancies after radiation therapy for breast cancer: Comprehensive results. Breast. 2017 Oct;35:122-129.
DoseRT is a Trademark of Vision RT. BeamSite is a trademark of DoseOptics LLC.